BEUDAMED
    5,702 results · 46ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

    KMINA

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    KMINA

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    IMPROVING MOBILITY DEVELOPMENT, S.L.

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    IMPROVING MOBILITY DEVELOPMENT, SL

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    KMINA

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    IMPROVING MOBILITY DEVELOPMENT SL

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    KMINA

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    KMINA CORP

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    IMPROVING MOBILITY DEVELOPMENT SL

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    KMINA

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    KMINA

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    KMINA

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    IMPROVING MOBILITY DEVELOPMENT, SL

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    IMPROVING MOBILITY DEVELOPMENT, SL

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    KMINA

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    IMPROVING MOBILITY DEVELOPMENT SL

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    KMINA

    FDA registration
    IMPROVING MOBILITY DEVELOPMENT SL·1 product·🇪🇸 Spain

    P2psa

    FDA Pre-Market Approval
    FDA Class 3 ·Access Hybritech p2PSA Reagents on the Access Immunoassay Systems

    Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·Access Hybritech PSA Reagents on the Access Immunoassay Systems

    Kit, Test, Alpha-Fetoprotein For Neural Tube Defects

    FDA Pre-Market Approval
    FDA Class 3 ·Access AFP Reagents on the Access Immunoassay Systems